Who Owns Vor Biopharma Stock?
NASDAQ: VORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 89.58%
- Held by insiders
- 8.92%
- Institutional holders
- 212
- Institutions 89.6%
- Insiders 8.9%
- Public and other 1.5%
Who owns Vor Biopharma stock?
Institutional investors own about 89.6% of Vor Biopharma's shares, spread across 212 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 8.92% of VOR.
The largest institutional holders are FMR, LLC (11.00%), TCG Crossover Management, LLC (9.23%) and RA Capital Management, L.P. (7.33%). Together, the top 10 institutions control 57.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their VOR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VOR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 6.76M | 11.00% | +37.0% |
| TCG Crossover Management, LLC | 5.67M | 9.23% | 0.0% |
| RA Capital Management, L.P. | 4.50M | 7.33% | +87.5% |
| FCPM III Services B.V. | 3.41M | 5.54% | -17.3% |
| Blackrock Inc. | 3.31M | 5.38% | -4.7% |
| Venrock Adviser, LLC | 3.04M | 4.95% | 0.0% |
| Frazier Life Sciences Management, L.P. | 2.74M | 4.47% | +7.9% |
| Vanguard Capital Management LLC | 2.04M | 3.31% | -2.3% |
| State Street Corporation | 1.97M | 3.21% | -24.7% |
| Caligan Partners, LP | 1.93M | 3.13% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VOR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.55M | 2.52% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.40M | 2.28% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.27M | 2.07% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.09M | 1.78% |
| iShares Trust-iShares Russell 2000 ETF | 996.33K | 1.62% |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 758.11K | 1.23% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 650.68K | 1.06% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 531.07K | 0.86% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 492.15K | 0.80% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 454.10K | 0.74% |
Frequently asked questions
Who is the largest shareholder of Vor Biopharma?
FMR, LLC is the largest institutional shareholder of VOR, owning 11.00% of shares outstanding (6.76M shares) as of its latest 13F filing.
What percentage of Vor Biopharma is owned by institutions?
Institutions own about 89.6% of VOR shares and 98.3% of the public float.
How much of Vor Biopharma do insiders own?
Insiders, such as officers and directors, own about 8.92% of VOR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.